Insulin glargine U-300
These highlights do not include all the information needed to use INSULIN GLARGINE U-300 safely and effectively. See full prescribing information for INSULIN GLARGINE U-300. INSULIN GLARGINE U-300 (insulin glargine) injection, for subcutaneous use Initial U.S. Approval: 2015
99ea856d-9562-443a-9422-1006a3cff2f4
HUMAN PRESCRIPTION DRUG LABEL
Dec 7, 2023
Winthrop U.S, a business of sanofi-aventis U.S. LLC
DUNS: 824676584
Products 2
Detailed information about drug products covered under this FDA approval, including NDC codes, dosage forms, ingredients, and administration routes.
insulin glargine
Product Details
FDA regulatory identification and product classification information
FDA Identifiers
Product Classification
Product Specifications
INGREDIENTS (7)
insulin glargine
Product Details
FDA regulatory identification and product classification information